Correlation Engine 2.0
Clear Search sequence regions


  • adenocarcinoma (1)
  • cervix (1)
  • cervix uteri (1)
  • child (1)
  • diethylstilbestrol (7)
  • female (1)
  • human (2)
  • mother (1)
  • patient (1)
  • pregnancy (4)
  • women (2)
  • Sizes of these terms reflect their relevance to your search.

    To date, vaginal/cervical clear cell adenocarcinoma (CCAC) has not been reported in the granddaughters of women treated with diethylstilbestrol (DES) during pregnancy. We present an 8-year-old girl with a history of severe vaginal bleeding who was diagnosed with cervical CCAC. She underwent fertility-sparing surgery and radiotherapy. No sign of recurrence was detected throughout a 10-year follow-up. Her grandmother had received DES therapy during pregnancy with the patient's mother. Although no direct causal link is demonstrated, this case raises for the first time, the hypothesis of multigenerational effects of DES in girls and strongly suggests the need to follow the granddaughters of DES-treated women. © The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

    Citation

    Laura Gaspari, Françoise Paris, Nathalie Cassel-Knipping, Julia Villeret, Arnauld Verschuur, Marie-Odile Soyer-Gobillard, Xavier Carcopino-Tusoli, Samir Hamamah, Nicolas Kalfa, Charles Sultan. Diethylstilbestrol exposure during pregnancy with primary clear cell carcinoma of the cervix in an 8-year-old granddaughter: a multigenerational effect of endocrine disruptors? Human reproduction (Oxford, England). 2021 Jan 01;36(1):82-86

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33147330

    View Full Text